Dyspnoea management in acute coronary syndrome patients treated with ticagrelor

The occurrence of dyspnoea in acute coronary syndrome (ACS) patients has always been considered a challenging diagnostic and therapeutic clinical scenario. P2Y12 platelet receptor inhibitors (i.e., clopidogrel, prasugrel and ticagrelor) are currently the cornerstone of treatment of ACS patients. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Parodi, Guido, Storey, Robert F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acute Coronary Syndromes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657388/
https://www.ncbi.nlm.nih.gov/pubmed/25267878
http://dx.doi.org/10.1177/2048872614554108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657388/
https://www.ncbi.nlm.nih.gov/pubmed/25267878
http://dx.doi.org/10.1177/2048872614554108

Ejemplares similares